Close
Back to PAND Stock Lookup

(PAND) – FDA

Feb 22, 2021 08:31 AM Pandion Therapeutics (PAND) Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting
Jan 4, 2021 08:02 AM Pandion Therapeutics (PAND) Reports Positive Top-Line Phase 1a Clinical Data Demonstrating Proof of Mechanism of PT101

Back to PAND Stock Lookup